Therapeutic Developability Analysis

Antibody drug candidates with promising biochemical and biophysical properties can be selected at early stage of drug development. At LakePharma, a series of fast and small-scale tests, as well as in silico predictive tools are employed to serve as an additional selection criteria for better and safer therapeutic leads. 

-CE-SDS (Reducing and non-reducing)




-Octet (FcRn and Fc-gamma R binding profile)

-Sequence liability analysis

-PTM analysis

-Poly-specificity analysis

-Hydrophobicity assessment

-Forced degradation study


Please contact LakePharma at for custom quotes and details.

Cat.# Service Name Timeline Size Price Quantity Request